Cooper Companies, Inc. (The) (NYSE:COO) VP Randal Golden sold 1,621 shares of the stock in a transaction on Tuesday, July 11th. The shares were sold at an average price of $243.65, for a total value of $394,956.65. Following the sale, the vice president now owns 1,731 shares in the company, valued at $421,758.15. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Shares of Cooper Companies, Inc. (NYSE:COO) opened at 250.36 on Monday. The company has a market capitalization of $12.23 billion, a PE ratio of 37.54 and a beta of 0.61. The firm’s 50-day moving average price is $229.73 and its 200-day moving average price is $200.61. Cooper Companies, Inc. has a 12-month low of $158.73 and a 12-month high of $252.05.

Cooper Companies, Inc. (The) (NYSE:COO) last posted its earnings results on Thursday, June 1st. The medical device company reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.25 by $0.25. Cooper Companies, Inc. (The) had a net margin of 16.02% and a return on equity of 15.88%. The business had revenue of $522.40 million for the quarter, compared to analyst estimates of $520.71 million. During the same period in the prior year, the company posted $2.05 EPS. The company’s revenue for the quarter was up 8.0% on a year-over-year basis. On average, analysts expect that Cooper Companies, Inc. will post $9.61 EPS for the current fiscal year.

The business also recently declared a semiannual dividend, which will be paid on Monday, August 7th. Investors of record on Friday, July 21st will be paid a $0.03 dividend. This represents a yield of 0.02%. The ex-dividend date is Wednesday, July 19th. Cooper Companies, Inc. (The)’s dividend payout ratio is presently 0.90%.

WARNING: “Insider Selling: Cooper Companies, Inc. (The) (NYSE:COO) VP Sells $394,956.65 in Stock” was first published by Watch List News and is the property of of Watch List News. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.watchlistnews.com/insider-selling-cooper-companies-inc-the-nysecoo-vp-sells-394956-65-in-stock/1445279.html.

A number of equities analysts have recently issued reports on COO shares. Zacks Investment Research downgraded Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a research note on Thursday, June 1st. Piper Jaffray Companies restated an “overweight” rating and issued a $220.00 price target on shares of Cooper Companies, Inc. (The) in a research note on Thursday, April 6th. J P Morgan Chase & Co restated a “neutral” rating and issued a $206.00 price target (up from $200.00) on shares of Cooper Companies, Inc. (The) in a research note on Monday, June 5th. BMO Capital Markets restated an “outperform” rating and issued a $255.00 price target (up from $220.00) on shares of Cooper Companies, Inc. (The) in a research note on Monday, June 5th. Finally, Jefferies Group LLC restated a “buy” rating and issued a $250.00 price target (up from $220.00) on shares of Cooper Companies, Inc. (The) in a research note on Saturday, June 3rd. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $237.00.

A number of hedge funds and other institutional investors have recently modified their holdings of COO. Vanguard Group Inc. raised its position in shares of Cooper Companies, Inc. (The) by 5.4% in the first quarter. Vanguard Group Inc. now owns 4,781,732 shares of the medical device company’s stock worth $955,821,000 after buying an additional 244,531 shares in the last quarter. BlackRock Inc. raised its position in shares of Cooper Companies, Inc. (The) by 2,849.1% in the first quarter. BlackRock Inc. now owns 3,071,637 shares of the medical device company’s stock worth $613,991,000 after buying an additional 2,967,481 shares in the last quarter. Janus Capital Management LLC raised its position in shares of Cooper Companies, Inc. (The) by 35.7% in the first quarter. Janus Capital Management LLC now owns 1,743,182 shares of the medical device company’s stock worth $348,441,000 after buying an additional 458,173 shares in the last quarter. UBS Asset Management Americas Inc. raised its position in shares of Cooper Companies, Inc. (The) by 34.4% in the fourth quarter. UBS Asset Management Americas Inc. now owns 812,106 shares of the medical device company’s stock worth $142,062,000 after buying an additional 207,903 shares in the last quarter. Finally, Champlain Investment Partners LLC raised its position in shares of Cooper Companies, Inc. (The) by 6.6% in the first quarter. Champlain Investment Partners LLC now owns 524,375 shares of the medical device company’s stock worth $104,817,000 after buying an additional 32,270 shares in the last quarter. 98.09% of the stock is currently owned by hedge funds and other institutional investors.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Insider Buying and Selling by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.